Handbook of Clinical medicine

tamsulosin 400mcg/d PO; also alfuzosin, doxazosin, terazosin). Smooth muscle tone (prostate and bladder). SE: drowsiness; depression; dizziness; BP; dry mouth; ejaculatory failure; extra-pyramidal signs; nasal congestion; weight. • 5-reductase inhibitors: can be added, or used alone, eg fi nasteride 5mg/d PO (conversion of testosterone to the more potent androgen dihydrotestosterone). Excreted in semen, so use condoms; females should avoid handling. SE: impotence; libido. prostate size over 3–6mths and  long-term retention risk. • Surgery: • Transurethral resection of prostate (TURP) ≤14% become impotent (see BOX). Crossmatch 2U. Beware bleeding, clot retention, and post TURP syndrome: absorp- tion of washout causing CNS & CVS disturbance. ~12% need redoing within 8yrs. • Transurethral incision of the prostate (TUIP) involves less destruction than TURP, and less risk to sexual function, gives similar benefi t. Relieves pressure on the urethra. Maybe best surgical option for those with small glands <30g. • Retropubic prostatectomy is an open operation (if prostate very large). • Transurethral laser-induced prostatectomy (TULIP) may be as good as TURP. • Robotic prostatectomy is gaining popularity as a less traumatic and minimally invasive treatment option. Advice for patients concerning transurethral prostatectomy (TURP) Pre-op consent issues may centre on risks of the procedure,
